Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Genetics Navigator: a digital platform to guide people through genetic testing

Official title: The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services

Run by Unity Health Toronto · NCT06455384 · Data updated 2026-11-12

This randomized trial will test whether the Genetics Navigator digital platform helps adults and parents of children referred for clinical genetic testing have less distress and a smoother testing process compared with usual genetics appointments.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment170 (estimated)
SponsorUnity Health Toronto
Academic / other
Locations3 sites (Toronto, Ontario and 2 other locations)
StatusRecruiting
StartedOctober 28, 2025
Main results expectedMarch 2027
Study endsJuly 2027
Registry record updatedJune 24, 2026
Trial IDNCT06455384 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults referred for clinical genetic testing and parents or legal guardians of pediatric patients referred to participating clinicians at Mount Sinai Hospital, SickKids, or Sunnybrook in Toronto who are fluent in English and eligible for testing are ideal candidates.

Probably not a fit

Patients who need urgent or prenatal genetic testing, those not eligible for clinical genetic testing in Ontario, or those not fluent in English are unlikely to benefit from this platform-based pathway.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized controlled trial enrolling adults and parents of pediatric patients referred for clinical genetic testing at three Toronto hospitals. Participants are randomized to use the Genetics Navigator, an end-to-end e-health platform that provides education, a decision aid, family/history collection, and results delivery, or to standard care with genetics professionals. The study measures patient distress, decision quality, patient experience, and service efficiency. Results will determine whether the platform can substitute for or augment traditional genetics appointments.

Why it matters

Potential benefit: If successful, the Genetics Navigator could reduce waiting-related distress, improve patient understanding and decision making, and streamline delivery of genetic testing services.

How similar studies have gone: The team previously tested a related decision support tool (Genetics ADvISER) with promising results, but the Genetics Navigator is a broader end-to-end platform being tested in a randomized trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion:

* Adult patients (18 years of age or older) who are referred to participating clinicians at Mount Sinai Hospital for clinical genetic testing.
* Parents/legal guardians (18 years of age or older) of pediatric patients who are referred to participating clinicians at SickKids for clinical genetic testing.

Exclusion:

* Known not to be eligible for clinical genetic testing in Ontario
* Requires urgent clinical genetic testing or prenatal genetic testing
* Not fluent in English (speaking and reading)

Where it's running

  • Mount Sinai Hospital
    Toronto, Ontario, Canada
    Recruiting
  • The Hospital for Sick Children
    Toronto, Ontario, Canada
    Recruiting
  • Sunnybrook Hospital
    Toronto, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.